Skip to main content
Top
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022

08-01-2021 | Osteomalacia | Clinical Report

The Nose that Broke the Hip! Tumor Induced Osteomalacia Secondary to Phosphaturic Mesenchymal Nasal Tumor : A Case Report

Authors: Deepak Rangaswamy, Ravi Sachidananda, Srikanth Kanchana Pala, D. M. Mahesh, Nithya Venkataramani

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Special Issue 2/2022

Login to get access

Abstract

Tumor induced osteomalacia is a rare paraneoplastic syndrome caused by usually small mesenchymal tumors. The tumors are commonly located in the extremities whereas occurrence in the nasal cavity is quite rare. An 18 year old male presented with asymmetric weakness of both lower limbs and difficulty in walking since one year. On evaluation he was found to have open femur head physes and iliac apophyses, low serum Phosphorus, low vitamin D, normal serum calcium, elevated PTH & alkaline phosphatase levels. FGF-23 levels in serum were elevated. DOTA NOC PET CT revealed tumor in the left nasal cavity abutting the nasal septum. Surgical excision of the tumor resulted in normalisation of the serum levels of phosphorus, vitamin D and FGF-23. This case report indicates the importance of maintaining high clinical suspicion and early detection of causative tumor using appropriate imaging techniques.
Literature
1.
go back to reference Fukumoto S, Yamashita T (2007) FGF23 is a hormone-regulating phosphate metabolism—Unique biological characteristics of FGF23. Bone 40(5):1190–1195CrossRefPubMed Fukumoto S, Yamashita T (2007) FGF23 is a hormone-regulating phosphate metabolism—Unique biological characteristics of FGF23. Bone 40(5):1190–1195CrossRefPubMed
2.
go back to reference Jiang Y, Xia WB, Xing XP et al (2012) Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature. J Bone Miner Res 27:1967–75CrossRefPubMed Jiang Y, Xia WB, Xing XP et al (2012) Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature. J Bone Miner Res 27:1967–75CrossRefPubMed
3.
go back to reference Agrawal K, Bhadada S, Mittal BR et al (2015) Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med 40:e6-10CrossRefPubMed Agrawal K, Bhadada S, Mittal BR et al (2015) Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med 40:e6-10CrossRefPubMed
4.
go back to reference Breer S, Brunkhorst T, Beil FT et al (2014) 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT. Bone 64:222–7CrossRefPubMed Breer S, Brunkhorst T, Beil FT et al (2014) 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT. Bone 64:222–7CrossRefPubMed
5.
go back to reference Clifton-Bligh RJ, Hofman MS, Duncan E et al (2013) Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT. J Clin Endocrinol Metab 98:687–94CrossRefPubMed Clifton-Bligh RJ, Hofman MS, Duncan E et al (2013) Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT. J Clin Endocrinol Metab 98:687–94CrossRefPubMed
6.
go back to reference Shimada T, Kakitani M, Yamazaki Y et al (2004) “Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113(4):561–568CrossRefPubMedCentralPubMed Shimada T, Kakitani M, Yamazaki Y et al (2004) “Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113(4):561–568CrossRefPubMedCentralPubMed
7.
go back to reference Imanishi Y, Hashimoto J, Ando W et al (2012) Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia. J Bone Miner Metab 30(1):93–99CrossRefPubMed Imanishi Y, Hashimoto J, Ando W et al (2012) Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia. J Bone Miner Metab 30(1):93–99CrossRefPubMed
8.
go back to reference Lee J-C, Su SY, Changou CA et al (2016) Characterization of FN1–FGFR1 and novel FN1–FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Mod Pathol 29(11):1335–1346CrossRefPubMed Lee J-C, Su SY, Changou CA et al (2016) Characterization of FN1–FGFR1 and novel FN1–FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Mod Pathol 29(11):1335–1346CrossRefPubMed
10.
go back to reference Hautmann AH, Hautmann MG, Kolbl O et al (2015) Tumor-induced osteomalacia: an up-to-date review. Curr Rheumatol Rep 17:512CrossRefPubMed Hautmann AH, Hautmann MG, Kolbl O et al (2015) Tumor-induced osteomalacia: an up-to-date review. Curr Rheumatol Rep 17:512CrossRefPubMed
Metadata
Title
The Nose that Broke the Hip! Tumor Induced Osteomalacia Secondary to Phosphaturic Mesenchymal Nasal Tumor : A Case Report
Authors
Deepak Rangaswamy
Ravi Sachidananda
Srikanth Kanchana Pala
D. M. Mahesh
Nithya Venkataramani
Publication date
08-01-2021
Publisher
Springer India
Published in
Indian Journal of Otolaryngology and Head & Neck Surgery / Issue Special Issue 2/2022
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-020-02348-0

Other articles of this Special Issue 2/2022

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022 Go to the issue